agios pharmaceuticals inc
(AGIO:Consolidated Issue Listed on NASDAQ Global Select )
David P. Schenkein M.D.
Chief Executive Officer, President and Director, Agios Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 47 board members in 4 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. David P. Schenkein, M.D., has been the Chief Executive Officer at Agios Pharmaceuticals, Inc. since August 2009 and serves as its President. Dr. Schenkein served as a Senior Vice President of Clinical Hematology & Oncology at Genentech, Inc. Additionally, Dr. Schenkein is an Associate Professor of Medicine at Tufts University School of Medicine. He serves as an adjunct Clinical Professor of Medicine at the Stanford University Cancer Center. He has been a Medical ...
38 Sidney StreetPhone: 617-649-8600
Cambridge, Massachusetts 02139
Board Members Memberships*
Chief Executive Officer, President and Director
Director, Chairman of Nominating & Corporate Governance Committee, Member of Transaction Committee and Member of Audit Committee
Director and Chairman of Nominating & Corporate Governance Committee
SUNY Upstate Medical University
|There is no Competitor Compensation data available.|